Robert A. Kaiser

5.3k total citations · 2 hit papers
41 papers, 4.2k citations indexed

About

Robert A. Kaiser is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert A. Kaiser has authored 41 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert A. Kaiser's work include Virus-based gene therapy research (11 papers), Signaling Pathways in Disease (8 papers) and CRISPR and Genetic Engineering (6 papers). Robert A. Kaiser is often cited by papers focused on Virus-based gene therapy research (11 papers), Signaling Pathways in Disease (8 papers) and CRISPR and Genetic Engineering (6 papers). Robert A. Kaiser collaborates with scholars based in United States, Spain and Netherlands. Robert A. Kaiser's co-authors include Jeffery D. Molkentin, Christopher Baines, Jeffrey Robbins, Eric W. Brunskill, Nicole H. Purcell, William J. Craigen, Tatiana Sheiko, M. Richard Sayen, Gerald W. Dorn and Hanna Osińska and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert A. Kaiser

40 papers receiving 4.1k citations

Hit Papers

Loss of cyclophilin D reveals a critical role for mitocho... 2005 2026 2012 2019 2005 2007 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Kaiser United States 19 3.1k 824 691 465 378 41 4.2k
Nicole H. Purcell United States 21 3.2k 1.0× 767 0.9× 618 0.9× 484 1.0× 418 1.1× 29 4.6k
Angel Aponte United States 36 2.8k 0.9× 512 0.6× 538 0.8× 345 0.7× 840 2.2× 69 4.4k
Matthias Szabolcs United States 40 2.7k 0.9× 624 0.8× 518 0.7× 222 0.5× 720 1.9× 80 5.1k
Shigeki Miyamoto United States 40 3.9k 1.2× 1.3k 1.6× 454 0.7× 735 1.6× 709 1.9× 72 5.8k
Scot J. Matkovich United States 38 3.8k 1.2× 1.5k 1.8× 301 0.4× 706 1.5× 285 0.8× 82 5.3k
Xinli Hu China 35 2.3k 0.8× 686 0.8× 452 0.7× 471 1.0× 628 1.7× 88 3.7k
Clifford D.L. Folmes United States 26 2.9k 1.0× 1.1k 1.3× 390 0.6× 443 1.0× 1.0k 2.7× 37 4.9k
Éva Kiss Germany 33 1.7k 0.6× 698 0.8× 243 0.4× 257 0.6× 413 1.1× 86 4.1k
Zoltán Giricz Hungary 28 2.4k 0.8× 816 1.0× 705 1.0× 318 0.7× 368 1.0× 89 3.9k
Hisakazu Ogita Japan 38 2.4k 0.8× 1.1k 1.3× 412 0.6× 281 0.6× 474 1.3× 100 4.9k

Countries citing papers authored by Robert A. Kaiser

Since Specialization
Citations

This map shows the geographic impact of Robert A. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Kaiser more than expected).

Fields of papers citing papers by Robert A. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Kaiser. The network helps show where Robert A. Kaiser may publish in the future.

Co-authorship network of co-authors of Robert A. Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Kaiser. A scholar is included among the top collaborators of Robert A. Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Kaiser. Robert A. Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolas, Clara T., Raymond Hickey, Zeji Du, et al.. (2022). In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions. Nature Communications. 13(1). 5012–5012. 16 indexed citations
2.
Mondal, Gourish, Clara T. Nicolas, Whitney S. Thompson, et al.. (2022). Activation of homology-directed DNA repair plays key role in CRISPR-mediated genome correction. Gene Therapy. 30(3-4). 386–397. 1 indexed citations
3.
Kaiser, Robert A., Maria Haller, Petra Apfalter, Heidrun Kerschner, & Daniel Cejka. (2021). Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients. Kidney International. 100(3). 697–698. 23 indexed citations
4.
Kaiser, Robert A., Daniel F. Carlson, Dennis A. Webster, et al.. (2021). Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing. PLoS ONE. 16(1). e0245831–e0245831. 8 indexed citations
5.
Kaiser, Robert A., et al.. (2019). Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models. PubMed. 30(2). 57–66. 7 indexed citations
6.
Kaiser, Robert A., Shennen A. Mao, Jaime Glorioso, et al.. (2018). Lentiviral Vector-mediated Gene Therapy of Hepatocytes <em>Ex Vivo</em> for Autologous Transplantation in Swine. Journal of Visualized Experiments. 5 indexed citations
7.
Nicolas, Clara T., Raymond Hickey, Zeji Du, et al.. (2018). Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models. Surgery. 164(3). 473–481. 18 indexed citations
8.
Kaiser, Robert A., et al.. (2015). Telemetric assessment of social and single housing: Evaluation of electrocardiographic intervals in jacketed cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods. 75. 38–43. 8 indexed citations
9.
York, Allen J., Michelle A. Sargent, Robert A. Kaiser, et al.. (2007). Inducible and myocyte-specific inhibition of PKCα enhances cardiac contractility and protects against infarction-induced heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 293(6). H3768–H3771. 37 indexed citations
10.
Baines, Christopher, Robert A. Kaiser, Tatiana Sheiko, William J. Craigen, & Jeffery D. Molkentin. (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nature Cell Biology. 9(5). 550–555. 759 indexed citations breakdown →
11.
Oka, Toru, Jian Xu, Robert A. Kaiser, et al.. (2007). Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling. Circulation Research. 101(3). 313–321. 413 indexed citations
12.
Sanna, Bastiano, Eric B. Brandt, Robert A. Kaiser, et al.. (2006). Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proceedings of the National Academy of Sciences. 103(19). 7327–7332. 102 indexed citations
13.
Kaiser, Robert A., Qiangrong Liang, Orlando F. Bueno, et al.. (2005). Genetic Inhibition or Activation of JNK1/2 Protects the Myocardium from Ischemia-Reperfusion-induced Cell Death in Vivo. Journal of Biological Chemistry. 280(38). 32602–32608. 103 indexed citations
14.
Kaiser, Robert A., Jefferson M. Lyons, Jodie Y. Duffy, et al.. (2005). Inhibition of p38 reduces myocardial infarction injury in the mouse but not pig after ischemia-reperfusion. American Journal of Physiology-Heart and Circulatory Physiology. 289(6). H2747–H2751. 35 indexed citations
15.
Baines, Christopher, Robert A. Kaiser, Nicole H. Purcell, et al.. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 434(7033). 658–662. 1792 indexed citations breakdown →
16.
Lips, Daniel J., Orlando F. Bueno, Benjamin J. Wilkins, et al.. (2004). MEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo. Circulation. 109(16). 1938–1941. 193 indexed citations
17.
Kaiser, Robert A. & Iain L. O. Buxton. (2002). Nucleotide‐mediated relaxation in guinea‐pig aorta: selective inhibition by MRS2179. British Journal of Pharmacology. 135(2). 537–545. 28 indexed citations
18.
Buxton, Iain L. O., et al.. (2001). NO‐induced relaxation of labouring and non‐labouring human myometrium is not mediated by cyclic GMP. British Journal of Pharmacology. 134(1). 206–214. 40 indexed citations
19.
Kaiser, Robert A., et al.. (1996). Human Gene Therapy in Gastrointestinal Diseases: In Vivo and In Vitro Approaches. Recent results in cancer research. 142. 51–61. 1 indexed citations
20.
Kaiser, Robert A.. (1975). Syntactic Complexity of Primary Grade Reading Materials: A Preliminary Look.. The Reading Teacher. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026